Online citations, reference lists, and bibliographies.
← Back to Search

Botulinum Toxin A In The Hemiplegic Upper Limb: A Double‐blind Trial

L. Arens, R. Goldschmidt, P. M. Leary
Published 1997 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share



This paper is referenced by
10.1080/17518420902927994
Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A
E. Guettard (2009)
10.5535/arm.2013.37.3.328
Botulinum Toxin Treatment on Upper Limb Function in School Age Children With Bilateral Spastic Cerebral Palsy: One Year Follow-up
Jee Sun Lee (2013)
Use of intramuscular botulinum toxin in Malaysian children with cerebral palsy.
T. B. Khoo (2007)
10.3109/15569543.2014.896020
Potential of Botulinum toxin A to treat upper extremity spasticity in children with cerebral palsy
Irene Nikaina (2014)
10.1097/00004694-200309000-00021
Pharmacologic Management of Spasticity in Cerebral Palsy
J. Mooney (2003)
10.1111/j.1469-8749.2002.tb00772.x
Functional outcome of botulinum toxin A injections to the lower limbs in cerebral palsy
D. Reddihough (2002)
10.1080/13638490500523234
Upper limb function after botulinum toxin A treatment in cerebral palsy: Two years follow-up of six cases
H. Sätilä (2006)
10.1155/2014/105953
Functional Popliteal Artery Entrapment Syndrome: Poorly Understood and Frequently Missed? A Review of Clinical Features, Appropriate Investigations, and Treatment Options
M. Hislop (2014)
10.1046/j.1468-1331.2001.00036.x
Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy
H. Graham (2001)
10.1111/j.1469-8749.2000.tb00022.x
Biomechanical transformation of the gastroc‐soleus muscle with botulinum toxin A in children with cerebral palsy
R. Boyd (2000)
10.5694/j.1326-5377.2003.tb05083.x
Developing a core clinical data set for cancer
M. Staples (2003)
A Study of Effect of Botulinum Toxin a on Hand Functions in Patients with Spastic Disorders
Amit Ranjan (2017)
10.1046/j.1468-1331.2001.00046.x
Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: clinical implications
I. Autti-Rämö (2001)
10.1046/j.1468-1331.2001.00047.x
Botulinum toxin type A injections in the spastic upper extremity of children with hemiplegia: child characteristics that predict a positive outcome
D. Fehlings (2001)
10.2106/JBJS.RVW.19.00119
Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy
Sara M Farag (2020)
10.2106/JBJS.H.00901
Botulinum neurotoxin as a therapeutic modality in orthopaedic surgery: more than twenty years of experience.
T. Seyler (2008)
10.1111/dmcn.14297
Botulinum neurotoxin A, blinding, and bias
T. Hastings-Ison (2019)
10.1111/j.1469-8749.2001.tb00762.x
Management of cerebral palsy: equinus gait
M. Goldstein (2001)
10.1136/jnnp.69.2.143
Botulinum toxin and spasticity
E. C. Davis (2000)
10.1177/0269215508099860
Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials
C. Albavera-Hernández (2009)
10.1097/BPB.0b013e3283320c52
Shoulder external rotator selective neurotomy in cerebral palsy: anatomical study and preliminary clinical results
Frank Fitoussi (2010)
10.5435/00124635-200309000-00001
Botulinum neurotoxin type A.
M. Delgado (2003)
10.1080/J006v25n03_04
Improving the Use of Hands in Daily Activities
A. Eliasson (2005)
10.1111/j.1469-8749.2002.tb00268.x
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double‐blind, placebo‐controlled, dose‐ranging study
R. Baker (2002)
10.1080/09638280701568437
The role of botulinum toxin injections in the management of muscle overactivity of the lower limb
Jean-Michel Gracies (2007)
10.1097/01253086-200125030-00003
Examination and Management of Spasticity and Weakness
C. Leonard (2001)
10.1080/13638490500235581
A comparison of goal attainment scaling and the Canadian occupational performance measure for paediatric rehabilitation research
A. Cusick (2006)
10.1111/j.1469-8749.2005.tb01173.x
Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy
L. Speth (2005)
10.1111/j.1469-8749.2009.03387.x
Repeat botulinum toxin‐A injections in the upper limb of children with hemiplegia: a randomized controlled trial
Christine A Olesch (2010)
10.1212/01.wnl.0000311391.00944.c4
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of NeurologySYMBOL
D. Simpson (2008)
10.2147/NDT.S1612
Neurologic uses of botulinum neurotoxin type A
J. Ney (2007)
10.1136/dtb.2000.38644
The management of spasticity
Patricia W. Nance (2000)
See more
Semantic Scholar Logo Some data provided by SemanticScholar